
Genesco Inc.
GCONYSEConsumer Cyclical● Active
$39.21
+$1.28(+3.37%)
Market Cap$435355492
P/E Ratio—
52W High$40.04
52W Low$19.62
Genesco Inc.(GCO)· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。
FMP · GCO · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2026-01 | 2025-02 | 2024-02 | 2023-01 | 2022-01 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $2.44B | $2.33B | $2.32B | $2.38B | $2.42B |
| Cost of Revenue | $1.31B | $1.23B | $1.23B | $1.25B | $1.24B |
| Gross Profit | $1.13B | $1.10B | $1.10B | $1.14B | $1.18B |
| Gross Margin %(computed) | 46.26% | 47.17% | 47.27% | 47.64% | 48.77% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $1.10B | $1.08B | $1.08B | $1.04B | $1.03B |
| Operating Income | $0.03B | $0.02B | $0.02B | $0.09B | $0.15B |
| Operating Margin %(computed) | 1.04% | 0.74% | 0.72% | 3.95% | 6.09% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.01B | $0.00B | $0.00B |
| Income Before Tax | $0.01B | $0.01B | ($0.02B) | $0.09B | $0.15B |
| Income Tax Expense | ($0.00B) | $0.03B | $0.00B | $0.02B | $0.04B |
| Net Income | $0.01B | ($0.02B) | ($0.02B) | $0.07B | $0.11B |
| Net Margin %(computed) | 0.54% | -0.81% | -0.72% | 3.02% | 4.74% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $1.28 | $-1.74 | $-1.50 | $5.77 | $8.11 |
| Wtd Avg Shares | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B |
| EBITDA | $0.07B | $0.07B | $0.04B | $0.14B | $0.20B |
| EBITDA Margin %(computed) | 2.90% | 2.87% | 1.54% | 5.71% | 8.19% |
数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · B
深入了解Genesco Inc.
关于Genesco Inc.(GCO)损益表
Genesco Inc.(GCO)损益表数据来源于SEC Form 10-K及10-Q申报文件。2026财年,GCO实现营收$2.44B,毛利润$1.13B(毛利率46.26%),净利润$0.01B(净利率0.54%)。
常见问题
GCO · 4 问Genesco Inc.(GCO)2026财年营收为$2.44B,同比up4.8%。
GCO revenueGCO salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08